Please complete the CAPTCHA to continue
@castlecreekpharma.com
✓
3 phones found area 862 and 847
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Michael Derby is listed as Managing Partner at TardiMed Sciences at TardiMed Sciences, based in New York City Metropolitan Area, United States. AeroLeads shows a work email signal at castlecreekpharma.com, phone signal with area code 862, 847, and a matched LinkedIn profile for Michael Derby.
Michael Derby previously worked as Managing Partner at Tardimed Sciences and Founder and Chief Executive Officer at Castle Creek Pharmaceuticals. Michael Derby holds Mba, Finance, Entrepreneurship from New York University.
This section adds company-level context without repeating Michael Derby's masked contact details.
AeroLeads found 1 current-domain work email signal for Michael Derby. Compare company email patterns before reaching out.
Successful entrepreneur, operating executive and investor, with 26 years of experience in the biopharmaceutical industry and broader life sciences sector. Founder or Co-Founder of six biopharmaceutical companies, with a passion for developing and commercializing innovative products that can make a major impact on the lives of patients globally.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Woodcliff Lake, New Jersey, Us
TardiMed Sciences is a life sciences investment and company creation firm. Our team of seasoned biopharmaceutical entrepreneurs have founded, built and exited companies across the spectrum of development stage and commercial stage entities, with a particular focus on de-risked clinical stage assets that have a differentiated profile targeting substantial markets, with the potential to make a major impact on the lives of patients globally.
Basking Ridge, New Jersey, Us
Castle Creek Pharma is a high growth biopharmaceutical company developing innovative therapies for patients with rare, serious or debilitating dermatologic conditions. The company has a robust and diversified pipeline of late-stage products that have the potential to transform lives.
Marathon Pharmaceuticals was a biopharmaceutical company that developed new treatments for rare diseases with a focus on providing medicine to patients who had no treatment options. The company developed a pipeline of treatments for rare neurologic and movement disorders. Marathon was sold to PTC Therapeutics in 2017.
Norphan Pharmaceuticals was a specialty pharmaceutical company focused on the development of drugs for orphan neurology conditions. Norphan was sold to Marathon Pharmaceuticals in 2013.
Quick answers generated from the profile data available on this page.
Michael Derby works for TardiMed Sciences.
Michael Derby is listed as Managing Partner at TardiMed Sciences at TardiMed Sciences.
AeroLeads has found 1 work email signal at @castlecreekpharma.com for Michael Derby at TardiMed Sciences.
AeroLeads has found 3 phone signal(s) with area code 862, 847 for Michael Derby at TardiMed Sciences.
Michael Derby is based in New York City Metropolitan Area, United States while working with TardiMed Sciences.
Michael Derby has worked for Tardimed Sciences, Castle Creek Pharmaceuticals, Marathon Pharmaceuticals, Norphan Pharmaceuticals, and Centerstone Partners.
You can use AeroLeads to view verified contact signals for Michael Derby at TardiMed Sciences, including work email, phone, and LinkedIn data when available.
Michael Derby holds Mba, Finance, Entrepreneurship from New York University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts